最終更新日：2025/11/25
The clinical trial reported that anatumomab mafenatox produced promising tumor reductions in patients with advanced non-small-cell lung cancer.
正解を見る
The clinical trial reported that anatumomab mafenatox produced promising tumor reductions in patients with advanced non-small-cell lung cancer.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
